Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,445.00
Bid: 4,430.00
Ask: 4,440.00
Change: 50.00 (1.14%)
Spread: 10.00 (0.226%)
Open: 4,515.00
High: 4,515.00
Low: 4,395.00
Prev. Close: 4,395.00
CWK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Third quarter trading statement

2 Feb 2023 07:00

RNS Number : 6545O
Cranswick PLC
02 February 2023
 

2 February 2023

 

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

 

Third quarter trading statement

 

Cranswick, a leading UK food producer, today provides its scheduled update on trading for the 13 weeks to 24 December 2022.

 

Current trading

Revenue growth accelerated in the third quarter, building on the momentum generated in the first half of the year. All four product categories were strongly ahead of the corresponding period in our core UK market, reflecting solid underlying volume growth together with further cost inflation recovery. Trading in December was particularly robust, underpinned by strong demand for our Fresh Pork, Convenience and Gourmet festive range of products. Our customers and consumers continue to recognise and appreciate the quality, value and versatility of pork.

 

Poultry revenue growth reflected a positive contribution from the new Hull breaded poultry facility which offset lower sales from the Hull cooked poultry facility. There was a very limited impact on Fresh Poultry revenue following Avian Influenza outbreaks at five farms across our poultry farm estate early in the period; we have received full financial compensation for all lost birds. In recent weeks the incidence of confirmed cases in the UK has reduced, but we continue to enforce strict biosecurity protocols across all our farms.

 

Far East export sales were well ahead of the same period last year, with slightly lower volumes comfortably offset by significantly stronger pricing.

 

Cranswick Pet Products made a modest contribution to Group revenue in the third quarter. During the period we made further progress in reshaping the business for the future to create a more efficient manufacturing operation with a strong complementary customer base.

 

Investment

Our broad-based investment plans remain firmly on track with several substantial projects in progress which will enhance the capability of and add capacity to several of our flagship production facilities as well as driving through further operating efficiencies. We have also committed to a number of capital projects which support our 'Second Nature' sustainability programme.

 

During the period we invested further in our pig farming operations and, in so doing, we have lifted our self-sufficiency to over 40% of our total requirement for British pigs.

 

Defined benefit pension scheme

A subsidiary of the Group operates a legacy defined benefit pension scheme for certain employees, towards which the Group was contributing cash of £1.8 million each year. In December 2022, a buy-in contract was purchased for £3.7 million, which secures members benefits in full, sees all the scheme's financial and demographic risks hedged and requires no further future cash contributions by Cranswick. 

 

'Second Nature' Sustainability

In December 2022 we received confirmation of our latest Carbon Disclosure Project (CDP) scores: grade A- for Climate and grade B- for Soya within Forests were both a grade improvement on the previous year. Our new, improved grades reflect our continued focus on and commitment to delivering our industry leading 'Second Nature' strategy.

 

Financial position

As expected, net debt increased during the period, reflecting the usual seasonal uplift in working capital, further investment in biological assets and our ongoing capital investment programme. The Group remains in a robust financial position with committed, unsecured facilities of £250 million providing comfortable headroom.

 

Outlook

The outlook for the current financial year remains in line with the Board's expectations.

 

The Board is confident that the continued focus on the strengths of the Company, which include its long-standing customer base, breadth and quality of products, robust financial position and industry leading asset infrastructure, will support the further successful development of Cranswick during the current year and over the longer term.

 

Preliminary results

The Company's next scheduled comment on trading will be the preliminary results announcement for the 52 weeks ending 25 March 2023, on Tuesday 23 May 2023.

 

Adam Couch, CEO of Cranswick, commented:

"We have delivered another strong quarter of growth, building on the momentum generated in the first half of the year. Our core UK market remains extremely resilient as our customers and the UK consumer continue to recognise and appreciate the quality, value and versatility of our pork and poultry product ranges.

 

"The broad-based inflationary pressure we are experiencing across our cost base continues to be well controlled and mitigated.

 

"Our relentless focus on innovation together with the passion and dedication of our people are the key enablers of our continued successful progress and development. I would like to thank all of our colleagues for their ongoing commitment and support."

 

Enquiries:

 

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Elizabeth Kittle

cranswick@powerscourt-group.com

 

Notes:

1. Cranswick is a leading and innovative supplier of premium, fresh and added-value food products. The business employs over 13,700 people and operates from 20 well-invested, highly efficient facilities in the UK.

 

Cranswick was formed in the early 1970s by farmers in East Yorkshire to produce animal feed and has since evolved into a business which produces a range of high quality, predominantly fresh food, including fresh pork, poultry, convenience, gourmet products and pet food. The business develops innovative, great tasting food products to the highest standards of food safety and traceability. The Group supplies the major grocery multiples as well as the growing premium and discounter retail channels. Cranswick also has a strong presence in the 'food-to-go' sector and a substantial export business. Results for the 52 weeks to 26 March 2022 showed revenue of £2,008.5m and profit before tax of £129.9m. For more information go to: www.cranswick.plc.uk

 

2. Cranswick is committed to ensuring that its business activities are sustainable from farm-to-fork. Its ambitious sustainability strategy 'Second Nature' has been developed to deliver the Group's vision to become the world's most sustainable meat business. Cranswick has committed to be a Net Zero business across its operations by 2040. Find out more at: www.thisissecondnature.co.uk

 

3. This information is based on information sourced from unaudited management accounts.

 

4. This announcement contains certain forward-looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLTFSILIIV
Date   Source Headline
26th Jul 20212:50 pmRNSAppointment of Chairman and Poll Result -2021 AGM
26th Jul 20212:48 pmRNSTransaction in Own Shares
26th Jul 20217:00 amRNSFirst quarter trading statement
13th Jul 20211:45 pmRNSANNUAL GENERAL MEETING 2021 – UPDATE
12th Jul 20213:46 pmRNSHolding(s) in Company
1st Jul 20218:59 amRNSTotal Voting Rights
24th Jun 20219:00 amRNSHolding(s) in Company
18th Jun 20212:24 pmRNSHolding(s) in Company
1st Jun 20212:35 pmRNSDirector/PDMR Shareholding
1st Jun 20212:25 pmRNSTotal Voting Rights
1st Jun 20212:24 pmRNSDirector/PDMR Shareholding
21st May 202111:00 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
21st May 202110:59 amRNSDirector/PDMR Shareholding
20th May 202112:08 pmRNSDirector/PDMR Shareholding
20th May 202112:06 pmRNSDirector/PDMR Shareholding
20th May 202112:03 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSChange of Chairmanship
18th May 20217:00 amRNSPreliminary Results
4th May 20213:56 pmRNSTotal Voting Rights
1st Apr 20213:32 pmRNSBlock listing Interim Review
1st Apr 20213:31 pmRNSBlock listing Interim Review
1st Apr 20213:29 pmRNSTotal Voting Rights
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:48 amRNSDirector/PDMR Shareholding
26th Mar 20219:47 amRNSDirector/PDMR Shareholding
23rd Mar 20216:03 pmRNSHolding(s) in Company
23rd Mar 20219:07 amRNSDirector/PDMR Shareholding
23rd Mar 20219:06 amRNSDirector/PDMR Shareholding
16th Mar 20211:29 pmRNSDirector/PDMR Shareholding
16th Mar 20218:30 amRNSNon-Executive Director Appointment
2nd Mar 20217:30 amRNSDirector/PDMR Shareholding
15th Feb 20212:59 pmRNSDirector/PDMR Shareholding
4th Feb 20217:00 amRNSThird Quarter Trading Statement
1st Feb 202110:29 amRNSTotal Voting Rights
28th Jan 20213:01 pmRNSAdditional Listing
28th Jan 20217:44 amRNSAdditional Listing
25th Jan 202112:31 pmRNSDirectorship
13th Jan 20218:38 amRNSHolding(s) in Company
4th Jan 20212:19 pmRNSTotal Voting Rights
24th Dec 20207:51 amRNSHolding(s) in Company
24th Dec 20207:49 amRNSDividend Announcement
17th Dec 20207:00 amRNSWithdrawal from Acquisition Process
16th Dec 202011:22 amRNSResponse to Press Speculation
11th Dec 20208:39 amRNSHolding(s) in Company
1st Dec 20208:26 amRNSTotal Voting Rights
24th Nov 20203:45 pmRNSHolding(s) in Company
24th Nov 20207:00 amRNSInterim Results
18th Nov 20204:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.